1Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study ofcholesterol lowering with simvastatin in 20536 high- risk individuals:a randomizedplacebo - controlled trial. Lancet 2002,360(9326) :7 - 22. 被引量：1
2Collins R, Armitage J, Parish S, Sleigh P, Peto R, the Heart Protection Study CollaborativeGroup: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963people with diabetes: a randomized placebo - controlled trial. Lancet 2003,361:2005 - 2016. 被引量：1
3Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high - risk in- clividuals: a randomized placebo- controlled trial [J]. Lancet, 2002, 360 (9326): 7-22. 被引量：1
4Nissen SE. Effect of intensive lipid lowering on progression of coronary atherosclerosis : evidence for an early benefit from the Reversal of Athero- sclerosis with Aggressive Lipid Lowering (REVERSAL) trial [ J]. Am J Cardiol, 2005, 96 (SA): 61F-68F. 被引量：1
5LaRosa JC, Grundy SM, Waters DD, et aL Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in pa- tients with stable coronary disease [J]. N Engl J Med, 2005, 352 (14) : 1425 - 1435. 被引量：1
6Ballantyne CM, Raichlen JS, Nieholls SJ, et al. Effect of rosuvastatin therapy on coronary artery stenosis assessed by quantitative coronary An- giography: a study to evaluate the effect of rosuvastatin on intravaseular uhmsound - derived coronary atheroma burden [J]. Circulation, 2008, 117 (19): 2458-2466. 被引量：1
7Nicholls SJ, Ballantyne CM, BarterPJ, et, al. Effect of two intensive statin regimens on progression of coronary disease [J]. N Engl J Med, 2011, 365 (22): 2078-2087. 被引量：1
8Grundy SM, Gleeman JL, Merz CN, et al. Implications ofrccent clin- ical trials for the National Cholesterol Education Program Adult Treatment Panellll guidelines [J]. Circulation, 2004, 110:227-239. 被引量：1
9The task force for the management of dyslipidaemias of the European So- ciety of Cardiology (ESC) and the European Atherosclerosis Society (ESA). ESC/ESA Guidelines for the management of dyslipidaemias [J]. EurHeartJ, 2011, 32: 1769-1818. 被引量：1
10Executive Summary of The Third Report of The National Cholesterol Ed- ucation Program (NCEP). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults ( Adult Treatment Panelll) [J]. JAMA, 2001, 285: 2486-2497. 被引量：1
